ilShinbiobase Co., Ltd. (068330) Financial Statements

― Followers

ilShinbiobase Co., Ltd. Financial Overview

ilShinbiobase Co., Ltd.'s market cap is currently ₩46.68B. The company's EPS TTM is ₩122.7; its P/E ratio is 10.24; and it has a dividend yield of 0.83%. ilShinbiobase Co., Ltd. is scheduled to report earnings on August 18, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	₩ 14.53B	₩ 10.82B	₩ 16.44B	₩ 20.43B	₩ 24.38B
Gross Profit	₩ 7.59B	₩ 6.28B	₩ 9.43B	₩ 10.51B	₩ 12.66B
Operating Income	₩ 4.56B	₩ 2.26B	₩ 6.21B	₩ 5.14B	₩ 7.34B
EBITDA	₩ 4.98B	₩ 2.70B	₩ 8.22B	₩ 5.17B	₩ 8.39B
Net Income	₩ 4.79B	₩ 3.81B	₩ 6.23B	₩ 3.82B	₩ 5.86B
Balance Sheet
Cash & Short-Term Investments	₩ 42.67B	₩ 37.24B	₩ 33.49B	₩ 27.71B	₩ 25.58B
Total Assets	₩ 68.58B	₩ 63.94B	₩ 60.62B	₩ 58.45B	₩ 56.44B
Total Debt	₩ 0.00	₩ 0.00	₩ 0.00	₩ 768.46K	₩ 9.87M
Net Debt	₩ -1.98B	₩ -1.73B	₩ -3.15B	₩ -5.71B	₩ -11.36B
Total Liabilities	₩ 3.79B	₩ 3.49B	₩ 3.55B	₩ 4.63B	₩ 6.36B
Stockholders' Equity	₩ 64.80B	₩ 60.45B	₩ 57.06B	₩ 53.82B	₩ 50.08B
Cash Flow
Free Cash Flow	₩ 5.26B	₩ 4.07B	₩ 5.66B	₩ 2.12B	₩ 5.97B
Operating Cash Flow	₩ 5.27B	₩ 4.12B	₩ 5.92B	₩ 2.65B	₩ 6.74B
Investing Cash Flow	₩ -4.73B	₩ -5.26B	₩ -5.81B	₩ -7.98B	₩ -4.11B
Financing Cash Flow	₩ -291.74M	₩ -291.74M	₩ -2.65B	₩ -309.30M	₩ -308.53M

Currency in KRW

ilShinbiobase Co., Ltd. Earnings and Revenue History

Income Statement >

ilShinbiobase Co., Ltd. Debt to Assets

Balance Sheet >

ilShinbiobase Co., Ltd. Cash Flow

Cash Flow >

ilShinbiobase Co., Ltd. Forecast EPS vs Actual EPS

Earnings >